{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:00:46Z","timestamp":1780621246653,"version":"3.54.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza University of Rome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>De-escalation from dual antiplatelet therapy (DAPT) to aspirin monotherapy is commonly performed after percutaneous coronary intervention to reduce bleeding risk. However, interindividual variability in platelet response exists, and high-on-aspirin residual platelet reactivity may predispose to thrombotic events. Platelet overexpression of multidrug resistance protein 4 (MRP4) has been proposed as a molecular mechanism contributing to aspirin low response, and it is a further risk factor for cardiovascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>An 82-year-old woman with a history of coronary artery disease presented with ST-elevation myocardial infarction 10 days after de-escalation from dual antiplatelet therapy (aspirin plus clopidogrel) to aspirin monotherapy. Coronary angiography revealed thrombotic occlusion of the proximal left anterior descending artery with in-stent restenosis. Platelet molecular analysis demonstrated increased MRP4 expression compared with aspirin-treated patients without acute coronary syndromes, suggesting impaired aspirin responsiveness consistent with a high-on-aspirin residual platelet reactivity phenotype. The patient was successfully treated with ticagrelor-based antiplatelet therapy and experienced no recurrent ischaemic or bleeding events during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case suggests that MRP4-mediated aspirin residual platelet function may contribute to thrombotic events following de-escalation to aspirin monotherapy. Assessment of platelet reactivity and molecular markers such as MRP4 expression, before switch from dual to single therapy, may help identify individuals at higher risk of aspirin failure and support a personalized approach to antiplatelet therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag385","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:43:29Z","timestamp":1779363809000},"source":"Crossref","is-referenced-by-count":0,"title":["ST-elevation myocardial infarction following de-escalation to aspirin monotherapy: evidence of residual platelet function MRP4 overexpression dependent case report"],"prefix":"10.1093","volume":"10","author":[{"given":"Vincenzo","family":"Cesario","sequence":"first","affiliation":[{"name":"Cardiology Unit, Cardiothoracic-Vascular and Heart Transplant Department, San Camillo Forlanini Hospital , Circonvallazione Gianicolense 87, Rome 00152 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7801-4646","authenticated-orcid":false,"given":"Eleonora","family":"Schiera","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome , Viale Regina Elena 324, Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaignazia","family":"Curreli","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome , Viale Regina Elena 324, Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0635-4921","authenticated-orcid":false,"given":"Giuliano","family":"Tocci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome , Sant\u2032Andrea Hospital, Via di Grottarossa 1035-1039, Rome 00189 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-396X","authenticated-orcid":false,"given":"Fabio Maria","family":"Pulcinelli","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome , Viale Regina Elena 324, Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"2026060420092677700_ytag385-B1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"2026060420092677700_ytag385-B2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2026060420092677700_ytag385-B3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11239-024-03022-w","article-title":"Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital","volume":"58","author":"Galli","year":"2025","journal-title":"J Thromb Thrombolysis"},{"key":"2026060420092677700_ytag385-B4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/ehjcvp\/pvaf034","article-title":"Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy","volume":"11","author":"Galli","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026060420092677700_ytag385-B5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jacc.2014.05.049","article-title":"Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry","volume":"64","author":"Mayer","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026060420092677700_ytag385-B6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2011.03.049","article-title":"Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting","volume":"58","author":"Mattiello","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026060420092677700_ytag385-B7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.117741","article-title":"Targeting MRP4 in drug resistance and aspirin treatment failure: implications for precision medicine","volume":"246","author":"De Corci","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"2026060420092677700_ytag385-B8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1160\/TH16-04-0316","article-title":"Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment","volume":"116","author":"Massimi","year":"2016","journal-title":"Thromb Haemost"},{"key":"2026060420092677700_ytag385-B9","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/eurheartj\/ehad362","article-title":"Personalised antiplatelet therapies for coronary artery disease: what the future holds","volume":"44","author":"Capodanno","year":"2023","journal-title":"Eur Heart J"},{"key":"2026060420092677700_ytag385-B10","article-title":"P2y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials","volume":"373","author":"Valgimigli","year":"2021","journal-title":"BMJ"},{"key":"2026060420092677700_ytag385-B11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4244\/EIJ-D-24-00973","article-title":"Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial","volume":"21","author":"Gitto","year":"2025","journal-title":"EuroIntervention"},{"key":"2026060420092677700_ytag385-B12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/eurheartj\/ehab836","article-title":"Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials","volume":"43","author":"Galli","year":"2022","journal-title":"Eur Heart J"},{"key":"2026060420092677700_ytag385-B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-026-01249-z","article-title":"Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies","author":"Galli","year":"2026","journal-title":"Nat Rev Cardiol"},{"key":"2026060420092677700_ytag385-B14","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.jcin.2024.08.027","article-title":"International consensus statement on platelet function and genetic testing in percutaneous coronary intervention: 2024 update","volume":"17","author":"Angiolillo","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"2026060420092677700_ytag385-B15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2025.100068","article-title":"Human and mouse platelet transcriptomes and proteomes for phenotyping 3474 genes with hemostatic and platelet traits","volume":"2","author":"Huang","year":"2025","journal-title":"Blood Vessel Thromb Hemost"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytag385\/68372391\/ytag385.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/6\/ytag385\/68372391\/ytag385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/6\/ytag385\/68372391\/ytag385.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:09:34Z","timestamp":1780618174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag385\/8691123"}},"subtitle":[],"editor":[{"given":"Elena","family":"Cavarretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"John","family":"Kanakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Mohamed","family":"Elbendary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"S\u00edmona","family":"Chiusolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag385","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,5,22]]},"article-number":"ytag385"}}